HK216896A - Pharmaceutical preparations - Google Patents

Pharmaceutical preparations

Info

Publication number
HK216896A
HK216896A HK216896A HK216896A HK216896A HK 216896 A HK216896 A HK 216896A HK 216896 A HK216896 A HK 216896A HK 216896 A HK216896 A HK 216896A HK 216896 A HK216896 A HK 216896A
Authority
HK
Hong Kong
Prior art keywords
pharmaceutical preparation
weight
polyethylene glycol
triazole derivative
denotes
Prior art date
Application number
HK216896A
Other languages
German (de)
English (en)
French (fr)
Inventor
Fries Walter
Original Assignee
Heinrich Mack Nachf.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Heinrich Mack Nachf. filed Critical Heinrich Mack Nachf.
Publication of HK216896A publication Critical patent/HK216896A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
HK216896A 1989-11-29 1996-12-19 Pharmaceutical preparations HK216896A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3939492A DE3939492A1 (de) 1989-11-29 1989-11-29 Pharmazeutische zubereitungen

Publications (1)

Publication Number Publication Date
HK216896A true HK216896A (en) 1996-12-27

Family

ID=6394433

Family Applications (1)

Application Number Title Priority Date Filing Date
HK216896A HK216896A (en) 1989-11-29 1996-12-19 Pharmaceutical preparations

Country Status (29)

Country Link
US (1) US5118698A (cs)
EP (1) EP0430149B1 (cs)
JP (1) JPH0660097B2 (cs)
KR (1) KR940000066B1 (cs)
CN (1) CN1035357C (cs)
AT (1) ATE102051T1 (cs)
AU (1) AU626480B2 (cs)
BR (1) BR9006025A (cs)
CA (1) CA2030911C (cs)
CY (1) CY1970A (cs)
CZ (1) CZ282898B6 (cs)
DE (2) DE3939492A1 (cs)
DK (1) DK0430149T3 (cs)
EG (1) EG19557A (cs)
ES (1) ES2062271T3 (cs)
FI (1) FI103713B1 (cs)
HK (1) HK216896A (cs)
HU (1) HU220867B1 (cs)
IE (1) IE64672B1 (cs)
IL (1) IL96450A (cs)
MX (1) MX23518A (cs)
MY (1) MY104540A (cs)
NO (1) NO180475C (cs)
NZ (1) NZ236255A (cs)
PT (1) PT96003B (cs)
RU (1) RU2038080C1 (cs)
SK (1) SK595390A3 (cs)
YU (1) YU227290A (cs)
ZA (1) ZA909549B (cs)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE164080T1 (de) * 1990-05-10 1998-04-15 Bechgaard Int Res Pharmazeutische zubereitung enthaltend n- glykofurole und n-äthylenglykole
US5397771A (en) * 1990-05-10 1995-03-14 Bechgaard International Research And Development A/S Pharmaceutical preparation
JP3485540B2 (ja) * 2000-12-28 2004-01-13 新日本製鐵株式会社 低騒音トランス
WO2002067899A1 (en) * 2001-02-28 2002-09-06 Akzo Nobel N.V. Injectable water-in-oil emulsions
EP1471887B1 (en) 2002-02-04 2010-04-21 Elan Pharma International Ltd. Nanoparticulate compositions having lysozyme as a surface stabilizer
EP2283864A1 (en) * 2002-07-16 2011-02-16 Elan Pharma International Ltd. Liquid dosage compositions fo stable nanoparticulate active agents

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1196284A (en) * 1982-05-28 1985-11-05 Joshua Oduro-Yeboah Pharmaceutical formulations
GR79307B (cs) * 1982-06-09 1984-10-22 Pfizer
DK476385A (da) * 1984-10-19 1986-04-20 Schering Corp 1,3-bis(1h-1,2,4-triazol-1-yl)-2-flour-2-(2,4-difluorphenyl)propan, antifungale midler indeholdende denne forbindelse, og fremgangsmaade til fremstilling af denne forbindelse

Also Published As

Publication number Publication date
EP0430149A3 (en) 1991-09-25
DK0430149T3 (da) 1994-03-28
PT96003A (pt) 1991-09-13
DE3939492A1 (de) 1991-06-06
NO905106L (no) 1991-05-30
DE69007029T2 (de) 1994-06-09
NO905106D0 (no) 1990-11-26
CN1035357C (zh) 1997-07-09
KR910009286A (ko) 1991-06-28
AU6706590A (en) 1991-08-08
HUT57039A (en) 1991-11-28
NO180475C (no) 1997-04-30
PT96003B (pt) 1998-01-30
IL96450A (en) 1994-10-21
EG19557A (en) 1997-08-31
EP0430149A2 (en) 1991-06-05
CY1970A (en) 1997-09-05
EP0430149B1 (en) 1994-03-02
JPH03176421A (ja) 1991-07-31
KR940000066B1 (ko) 1994-01-05
RU2038080C1 (ru) 1995-06-27
ATE102051T1 (de) 1994-03-15
YU227290A (sh) 1993-10-20
CA2030911C (en) 1995-02-07
FI905814L (fi) 1991-05-30
SK280599B6 (sk) 2000-04-10
ZA909549B (en) 1992-06-24
AU626480B2 (en) 1992-07-30
IE904282A1 (en) 1991-06-05
CA2030911A1 (en) 1991-05-30
JPH0660097B2 (ja) 1994-08-10
HU220867B1 (en) 2002-06-29
CZ595390A3 (en) 1997-06-11
BR9006025A (pt) 1991-09-24
US5118698A (en) 1992-06-02
IE64672B1 (en) 1995-08-23
CZ282898B6 (cs) 1997-11-12
MY104540A (en) 1994-04-30
ES2062271T3 (es) 1994-12-16
FI103713B (fi) 1999-08-31
SK595390A3 (en) 2000-04-10
NO180475B (no) 1997-01-20
DE69007029D1 (de) 1994-04-07
FI103713B1 (fi) 1999-08-31
NZ236255A (en) 1992-02-25
MX23518A (es) 1993-04-01
CN1052046A (zh) 1991-06-12
FI905814A0 (fi) 1990-11-26

Similar Documents

Publication Publication Date Title
EP0546018B1 (en) Pharmaceutical composition of florfenicol
EP0430149B1 (en) Pharmaceutical preparations
EP1713466B1 (en) Antiparasitic composition containing an organic amine salt of closantel
US5886018A (en) Pharmaceutical composition for parenteral administration containing an indole-carboxylic acid
US6596754B1 (en) Preventives/remedies for multiple organ failure
US6841576B2 (en) Anti-hypertensive composition and methods of treatment
US4389414A (en) Prostaglandin compositions
JP3098275B2 (ja) トルナフテート含有液剤
CS265238B2 (en) Method of injection applicable water solutions antimetic agent stabilization

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)